Safety of deferasirox in sickle cell disease patients with co-existing liver impairment.
Emmanouil
E
Sinakos
Efthimia
E
Vlachaki
Apostolos
A
Tsapas
D000755:Anemia, Sickle Cell / Q000628:therapy*; D001565:Benzoates / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007502:Iron Chelating Agents / Q000627:therapeutic use*; D019190:Iron Overload / Q000188:drug therapy*; D008297:Male; D065227:Transfusion Reaction; D014230:Triazoles / Q000627:therapeutic use*
D001565:Benzoates; D007502:Iron Chelating Agents; D014230:Triazoles